Breast cancer research could expand lung cancer therapies

New research into a genetic mutation’s role in breast cancer could open new treatment options for lung cancer, according to a Michigan State University scientist. “We sequenced the whole genome of breast cancer samples and found a driving mutation that hasn’t been recognized as important in lung cancer before,” said Eran Andrechek, a College of Human Medicine physiology professor. “This mutation has clear potential to identify lung cancer patients who should be receiving targeted therapy that’s already approved by the FDA.”